Anthill Ventures announces cohort for healthtech start-ups

BL Hyderabad Bureau Updated - May 31, 2023 at 10:13 AM.

Start-ups in the programme will be provided access to wet lab facilities, clinical validation support, and evaluation of their market-ready solutions

Prasad Vanga, CEO of Anthill Ventures

Venture capital firm Anthill Ventures has called for applications from healthtech start-ups for its new cohort, Lumos Health programme, which is aimed at supporting start-ups with disruptive solutions and health technologies. 

“The programme will provide start-ups access to Anthill’s global network of investors, mentors, and industry experts, as well as a range of resources designed to help start-ups grow their businesses,” said Prasad Vanga, Founder and Managing Partner, Anthill Ventures.

“We have partnerships with the Mazumdar Shaw Medical Foundation, Kauvery Hospitals, DERBI Foundation and Makers Nest, providing start-ups access to 51 hospitals across the country through partners,” he said in a statement on Tuesday.

Also read: Global Innovation Alliance. Anthill Ventures grooms 5 Singapore start-ups

Start-ups will be provided access to wet lab facilities, clinical validation support, and comprehensive evaluation of their market-ready solutions. The programme is also supported by partner HealthCare Global (HCG).

The programme will also support start-ups on regulatory processes, funding advice and market access.  

Published on May 31, 2023 04:41

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

TheHindu Businessline operates by its editorial values to provide you quality journalism.

This is your last free article.